Bildkälla: Stockfoto

BioInvent: New Readout in Phase I/IIa trial of BI-1206 - Redeye

Redeye comments on the new data presented by BioInvent from the intravenous arm of the study.

Redeye comments on the new data presented by BioInvent from the intravenous arm of the study.
Börsvärldens nyhetsbrev
ANNONSER